Market Cap 5.34B
Revenue (ttm) 0.00
Net Income (ttm) -182.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 465,100
Avg Vol 826,120
Day's Range N/A - N/A
Shares Out 68.32M
Stochastic %K 61%
Beta 1.41
Analysts Strong Sell
Price Target $96.85

Company Profile

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical t...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 394 5230
Address:
Building 17, Suite 102b 221 Crescent Street, Waltham, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 3:19 PM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $78.09, showing a strong upward trend with a recent RSI of 59.46, indicating bullish momentum but approaching overbought territory. The stock is above its 30-day MA of 71.89 and 50-day MA of 65.37, confirming positive sentiment. Directional Bias: The stock is positioned well within the 60-day high of $80.99 and low of $38.88, suggesting potential for further gains. The ATR of 3.16 indicates moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $78.09 - Stop Loss: $75.00 (3.99% below entry) - Take Profit Targets: 1. $81.00 (3.69% gain) 2. $84.00 (7.42% gain) 3. $91.50 (17.2% gain) With these targets, we aim for a minimum of 17% ROI on the third target while maintaining a favorable risk-reward ratio. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:15 PM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $77.35, with a strong upward momentum indicated by an RSI of 63.44. The stock is above its 30-day MA of 69.14 and 50-day MA of 63.37, suggesting bullish sentiment. The recent 60-day high of $78.15 shows potential resistance, while the low of $36.85 indicates a significant range for price movement. Directional Bias: The RSI is nearing overbought territory but remains below 70, indicating room for further gains. The stock's position above key moving averages supports a bullish outlook. Trade Plan: - Suggested Entry: $77.50 - Stop Loss: $74.00 (3.24% risk) - Take Profit Targets: 1. $80.00 (3.22% gain) 2. $82.00 (5.00% gain) 3. $90.50 (16.96% gain) With a focus on the bullish trend and strong technical indicators, this trade plan aims for a minimum 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JFDI
JFDI Dec. 19 at 2:02 PM
$APGE cc @Doozio
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:06 PM
Stephens & Co. updates rating for Apogee Therapeutics ( $APGE ) to Overweight, target set at 95.
0 · Reply
Quantumup
Quantumup Dec. 17 at 12:45 PM
H.C. Wainwright⬆️the PT on $NKTR to $135 from $120 and reiterated at a Buy rating. $LLY $REGN $SNY $APGE CRVS JNJ Here's what H.C. Wainwright had to say in its note: https://x.com/Quantumup1/status/2001272178008875122?s=20
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:00 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently positioned at $74.78, showing strength as it approaches the 60D high of $78.15. The RSI of 59.87 indicates bullish momentum, suggesting potential for upward movement. The moving averages (MA30 at 67.69 and MA50 at 62.06) are both trending upwards, reinforcing a positive directional bias. Trade Plan: - Suggested Entry: $75.00 - Stop Loss: $71.00 (below recent support) - Take Profit Targets: 1. $78.00 (approx. 4% gain) 2. $80.00 (approx. 6.67% gain) 3. $87.50 (approx. 16.67% gain) The third target provides a potential ROI of over 17%, aligning with our strategy. Monitor the ATR of 3.35 to adjust the stop loss as needed. This trade leverages the current bullish sentiment and technical indicators, aiming for significant upside potential. https://privateprofiteers.com
0 · Reply
Quantumup
Quantumup Dec. 16 at 4:13 PM
Oppenheimer⬆️ $NKTR's PT to $115 from $98 and reiterated at an Outperform rating. LLY $REGN SNY PFE ABBV $APGE $CRVS $JNJ Oppenheimer said in its note: NKTR provided updates on topline results from the Ph2b REZOLVE-AA study evaluating rezpeg in alopecia areata. While technically the study missed the primary endpoint (mean percent SALT change at week-36) by a whisker, excluding four patients with eligibility violations suggests a nominal statistical significance for both 24mcg/kg and 18mcg/kg doses. Moreover, about 15% of patients achieved SALT ≤20, which aligns with the lower end (15-25%) of the upside scenario outlined in our preview. Last, rezpeg showed a consistent safety profile with previously reported data. Taken together, we see compelling activity for rezpeg in AA, which, to our knowledge, is the first of its kind for a biologic (Exhibits 1-3). Our PT goes to $115 from $98 by increasing our estimated PoS for rezpeg in AA to 50%.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:33 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $77.08, showing strong momentum with an RSI of 74.68, indicating overbought conditions. The price is near the 60D high of $78.11, suggesting potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, a short-term pullback is likely. However, the MA30 (66.33) and MA50 (60.62) indicate a bullish trend in the medium term. Trade Plan: - Suggested Entry: $76.50 (slightly below current price to capture potential pullback) - Stop Loss: $74.00 (to limit downside risk) - Take Profit Targets: 1. $80.00 (4% ROI) 2. $82.50 (7% ROI) 3. $90.00 (17% ROI) With the potential for a 17% ROI on the third target, this trade offers a favorable risk-reward ratio. Monitor price action closely around the entry point and adjust stop loss as needed. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:26 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $76.76, showing strong bullish momentum with an RSI of 77.34, indicating overbought conditions. The recent 60D high is $77.5, suggesting resistance near this level, while the 60D low is $35.39, providing a significant range for potential movement. Directional Bias: The strong RSI indicates upward momentum, but caution is warranted due to the overbought signal. The 30-day moving average (MA30) at $65.64 and 50-day moving average (MA50) at $59.87 support a bullish outlook, as the price is well above these averages. Trade Plan: - Suggested Entry: $76.50 (slightly below the current price to capture any pullback) - Stop Loss: $73.00 (to limit downside risk) - Take Profit Targets: 1. $80.00 (5.9% ROI) 2. $85.00 (10.7% ROI) 3. $90.00 (17.2% ROI) This plan aims for a minimum of 17% ROI on the third target while managing risk effectively. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Dec. 10 at 3:58 PM
$APGE Opportunity Deutsche Bank initiates coverage with buy rating and PT $103 Deutsche Bank initiates coverage with buy rating; PT $103
0 · Reply
Latest News on APGE
Apogee Therapeutics to Participate in Upcoming Conferences

Nov 3, 2025, 7:30 AM EST - 7 weeks ago

Apogee Therapeutics to Participate in Upcoming Conferences


Apogee Therapeutics: Engineering Biologic Dominance

Apr 14, 2025, 8:04 AM EDT - 9 months ago

Apogee Therapeutics: Engineering Biologic Dominance


Apogee Therapeutics Announces Agenda for Virtual R&D Day

Nov 29, 2024, 1:00 PM EST - 1 year ago

Apogee Therapeutics Announces Agenda for Virtual R&D Day


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 3:19 PM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $78.09, showing a strong upward trend with a recent RSI of 59.46, indicating bullish momentum but approaching overbought territory. The stock is above its 30-day MA of 71.89 and 50-day MA of 65.37, confirming positive sentiment. Directional Bias: The stock is positioned well within the 60-day high of $80.99 and low of $38.88, suggesting potential for further gains. The ATR of 3.16 indicates moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $78.09 - Stop Loss: $75.00 (3.99% below entry) - Take Profit Targets: 1. $81.00 (3.69% gain) 2. $84.00 (7.42% gain) 3. $91.50 (17.2% gain) With these targets, we aim for a minimum of 17% ROI on the third target while maintaining a favorable risk-reward ratio. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:15 PM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $77.35, with a strong upward momentum indicated by an RSI of 63.44. The stock is above its 30-day MA of 69.14 and 50-day MA of 63.37, suggesting bullish sentiment. The recent 60-day high of $78.15 shows potential resistance, while the low of $36.85 indicates a significant range for price movement. Directional Bias: The RSI is nearing overbought territory but remains below 70, indicating room for further gains. The stock's position above key moving averages supports a bullish outlook. Trade Plan: - Suggested Entry: $77.50 - Stop Loss: $74.00 (3.24% risk) - Take Profit Targets: 1. $80.00 (3.22% gain) 2. $82.00 (5.00% gain) 3. $90.50 (16.96% gain) With a focus on the bullish trend and strong technical indicators, this trade plan aims for a minimum 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JFDI
JFDI Dec. 19 at 2:02 PM
$APGE cc @Doozio
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:06 PM
Stephens & Co. updates rating for Apogee Therapeutics ( $APGE ) to Overweight, target set at 95.
0 · Reply
Quantumup
Quantumup Dec. 17 at 12:45 PM
H.C. Wainwright⬆️the PT on $NKTR to $135 from $120 and reiterated at a Buy rating. $LLY $REGN $SNY $APGE CRVS JNJ Here's what H.C. Wainwright had to say in its note: https://x.com/Quantumup1/status/2001272178008875122?s=20
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:00 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently positioned at $74.78, showing strength as it approaches the 60D high of $78.15. The RSI of 59.87 indicates bullish momentum, suggesting potential for upward movement. The moving averages (MA30 at 67.69 and MA50 at 62.06) are both trending upwards, reinforcing a positive directional bias. Trade Plan: - Suggested Entry: $75.00 - Stop Loss: $71.00 (below recent support) - Take Profit Targets: 1. $78.00 (approx. 4% gain) 2. $80.00 (approx. 6.67% gain) 3. $87.50 (approx. 16.67% gain) The third target provides a potential ROI of over 17%, aligning with our strategy. Monitor the ATR of 3.35 to adjust the stop loss as needed. This trade leverages the current bullish sentiment and technical indicators, aiming for significant upside potential. https://privateprofiteers.com
0 · Reply
Quantumup
Quantumup Dec. 16 at 4:13 PM
Oppenheimer⬆️ $NKTR's PT to $115 from $98 and reiterated at an Outperform rating. LLY $REGN SNY PFE ABBV $APGE $CRVS $JNJ Oppenheimer said in its note: NKTR provided updates on topline results from the Ph2b REZOLVE-AA study evaluating rezpeg in alopecia areata. While technically the study missed the primary endpoint (mean percent SALT change at week-36) by a whisker, excluding four patients with eligibility violations suggests a nominal statistical significance for both 24mcg/kg and 18mcg/kg doses. Moreover, about 15% of patients achieved SALT ≤20, which aligns with the lower end (15-25%) of the upside scenario outlined in our preview. Last, rezpeg showed a consistent safety profile with previously reported data. Taken together, we see compelling activity for rezpeg in AA, which, to our knowledge, is the first of its kind for a biologic (Exhibits 1-3). Our PT goes to $115 from $98 by increasing our estimated PoS for rezpeg in AA to 50%.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:33 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $77.08, showing strong momentum with an RSI of 74.68, indicating overbought conditions. The price is near the 60D high of $78.11, suggesting potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, a short-term pullback is likely. However, the MA30 (66.33) and MA50 (60.62) indicate a bullish trend in the medium term. Trade Plan: - Suggested Entry: $76.50 (slightly below current price to capture potential pullback) - Stop Loss: $74.00 (to limit downside risk) - Take Profit Targets: 1. $80.00 (4% ROI) 2. $82.50 (7% ROI) 3. $90.00 (17% ROI) With the potential for a 17% ROI on the third target, this trade offers a favorable risk-reward ratio. Monitor price action closely around the entry point and adjust stop loss as needed. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:26 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $76.76, showing strong bullish momentum with an RSI of 77.34, indicating overbought conditions. The recent 60D high is $77.5, suggesting resistance near this level, while the 60D low is $35.39, providing a significant range for potential movement. Directional Bias: The strong RSI indicates upward momentum, but caution is warranted due to the overbought signal. The 30-day moving average (MA30) at $65.64 and 50-day moving average (MA50) at $59.87 support a bullish outlook, as the price is well above these averages. Trade Plan: - Suggested Entry: $76.50 (slightly below the current price to capture any pullback) - Stop Loss: $73.00 (to limit downside risk) - Take Profit Targets: 1. $80.00 (5.9% ROI) 2. $85.00 (10.7% ROI) 3. $90.00 (17.2% ROI) This plan aims for a minimum of 17% ROI on the third target while managing risk effectively. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Dec. 10 at 3:58 PM
$APGE Opportunity Deutsche Bank initiates coverage with buy rating and PT $103 Deutsche Bank initiates coverage with buy rating; PT $103
0 · Reply
Quantumup
Quantumup Dec. 10 at 12:54 PM
Deutsche Bank🏁 $APGE Buy/$103 $NKTR $CRVS KYMR $SNY - $REGN AMGN CLDX Here's what Deutsche Bank said in its APGE initiation report: https://x.com/Quantumup1/status/1998737304836272461?s=20
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 11:53 AM
Deutsche Bank has adjusted their stance on Apogee Therapeutics ( $APGE ), setting the rating to Buy with a target price of 103.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:29 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $74.74, showing strong momentum with an RSI of 73.53, indicating overbought conditions. The stock is above its 30-day moving average (MA30) of 64.28 and 50-day moving average (MA50) of 58.4, suggesting bullish sentiment. The recent 60-day high of $77.08 provides a resistance level to watch. Directional Bias: Given the high RSI and proximity to the 60D high, a pullback may occur, but the overall trend remains bullish due to the strong MAs. Trade Plan: - Suggested Entry: $74.00 (slightly below current price for a better entry) - Stop Loss: $70.00 (to limit risk) - Take Profit Targets: 1. $76.00 (2.7% gain) 2. $77.00 (2.8% gain) 3. $87.00 (16.4% gain) This plan provides a potential ROI of over 17% on the third target while maintaining a manageable risk. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 9 at 10:05 PM
$APGE Current Stock Price: $74.74 Contracts to trade: $75 APGE Dec 19 2025 Call Entry: $2.20 Exit: $3.73 ROI: 70% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:18 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $74.26, near its 60D high of $77.08. The RSI at 69.32 indicates overbought conditions, suggesting a potential pullback. However, the strong upward momentum reflected by the moving averages (MA30 at 63.6 and MA50 at 57.66) supports a bullish outlook in the short term. Directional Bias: Given the proximity to the 60D high and the high RSI, a cautious bullish stance is warranted. The price is above both the MA30 and MA50, indicating strength, but the overbought RSI suggests a possible correction before further gains. Trade Plan: - Suggested Entry: $74.50 - Stop Loss: $70.00 (risking $4.50) - Take Profit Targets: 1. $78.00 (Target 1: 4% gain) 2. $80.00 (Target 2: 7% gain) 3. $87.00 (Target 3: 17% gain) This plan provides a solid risk-reward ratio while targeting significant upside potential. Monitor for any signs of reversal near the entry point. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:17 AM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $75.5, nearing its 60D high of $77.0. The RSI at 76.25 indicates that the stock is overbought, suggesting a potential pullback. However, the strong momentum reflected in the RSI and the proximity to the recent high could lead to a short-term bullish trend. Directional Bias: While the RSI suggests overbought conditions, the stock's position above both the 30-day MA (62.14) and 50-day MA (56.16) indicates a strong bullish trend. The recent high-low range shows significant volatility, which can be leveraged for potential gains. Trade Plan: - Suggested Entry: $75.5 - Stop Loss: $71.5 (5.3% below entry) - Take Profit Targets: 1. $78.0 (3.3% gain) 2. $80.0 (5.8% gain) 3. $88.5 (17.2% gain) With a potential ROI of over 17% at target 3, this trade offers a solid risk-reward ratio. Monitor RSI for signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:52 PM
Actionable Trade Alert for $APGE: Market Context: $APGE is currently trading at $75.5, nearing its 60D high of $77.0. The RSI at 76.25 indicates that the stock is overbought, suggesting a potential pullback. However, the strong momentum reflected in the RSI and the proximity to the recent high could lead to a short-term bullish trend. Directional Bias: While the RSI suggests overbought conditions, the stock's position above both the 30-day MA (62.14) and 50-day MA (56.16) indicates a strong bullish trend. The recent high-low range shows significant volatility, which can be leveraged for potential gains. Trade Plan: - Suggested Entry: $75.5 - Stop Loss: $71.5 (5.3% below entry) - Take Profit Targets: 1. $78.0 (3.3% gain) 2. $80.0 (5.8% gain) 3. $88.5 (17.2% gain) With a potential ROI of over 17% at target 3, this trade offers a solid risk-reward ratio. Monitor RSI for signs of reversal. https://privateprofiteers.com
0 · Reply
Pika_Capital
Pika_Capital Dec. 4 at 1:44 AM
$ORKA $APGE $SYRE All 3 doubled pretty much. What a year for Pika. Ordered RTX 5090 as a Christmas gift 😂 time for upgrade baby.
1 · Reply
MaverikIT
MaverikIT Dec. 3 at 5:09 PM
$APGE +4.32 - knocking on door # 52wk$ @Doozio
0 · Reply
Social_Idiot
Social_Idiot Nov. 25 at 1:05 AM
$APGE Model showing: Measuring gap with sell signal. Low risk.
0 · Reply
Gemola
Gemola Nov. 14 at 4:46 PM
$APGE Double doji sandwich. boolish
0 · Reply
RunnerSignals
RunnerSignals Nov. 14 at 3:56 PM
breakout buzz $CDTX $RVMD $APGE $OWLT $CELC all tapping fresh 52-week highs. biotech acting like it found an extra gear today. what’s driving the surge? full breakdown inside. https://stocksrunner.com/news/2025-11-14-52-week-high-breakout-stocks-to-watch-right-now
0 · Reply